Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | DRD1 | P21728 | 8/20 | 0.37 |
| ▸ | DRD5 | P21918 | 4/20 | 0.37 |
| ▸ | DRD2 | P14416 | 2/20 | 0.34 |
| ▸ | MAP4K1 | Q92918 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9404251 | 0.85 | CYP3A4 (0.42) | CYP3A4CYP2D6DRD1DRD5DRD2 | |
| SCHEMBL9404228 | 0.85 | DRD1 (0.46) | CYP3A4CYP2D6DRD1DRD5DRD2 | |
| SCHEMBL7211621 | 0.83 | DRD1 (0.47) | CYP3A4CYP2D6DRD1DRD5DRD2 | |
| SCHEMBL29462305 | 0.83 | DRD1 (0.47) | CYP3A4CYP2D6DRD1DRD5DRD2 | |
| SCHEMBL1648925 | 0.83 | DRD1 (0.47) | CYP3A4CYP2D6DRD1DRD5DRD2 | |
| Bromide SCHEMBL9405370 | 0.82 | DRD1 (0.47) | CYP3A4CYP2D6DRD1DRD5DRD2 | |
| SCHEMBL8911123 | 0.76 | DRD1 (0.55) | CYP3A4CYP2D6DRD1DRD5DRD2 | |
| SCHEMBL10690321 | 0.74 | DRD1 (0.46) | CYP3A4CYP2D6DRD1DRD5DRD2 | |
| SCHEMBL7919604 | 0.73 | CYP3A4 (0.55) | CYP3A4CYP2D6DRD1DRD5CA1 | |
| SCHEMBL31257120 | 0.71 | DRD1 (0.45) | CYP3A4CYP2D6DRD1DRD5DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5079243-A | Nervous System Disorders, Antidopaminergic Effect | NOVO NORDISK A/S (DK) | 1992-01-07 | — | — | US | claimed |
| EP-0383247-B1 | Benzazepines with antidopaminergic activity | NOVO NORDISK AS (DK) | 1994-08-03 | — | — | EP | disclosed |
| US-5079243-A | Nervous System Disorders, Antidopaminergic Effect | NOVO NORDISK A/S (DK) | 1992-01-07 | — | — | US | disclosed |
| EP-0383247-A1 | Benzazepines with antidopaminergic activity | NOVO NORDISK A/S (DK) | 1990-08-22 | — | — | EP | disclosed |